These data provide evidence that increased levels of RAC1B in colorectal tumors may promote tumorigenesis by stimulating canonical NFκB signaling while circumventing a negative feedback from the RelB pathway [61]. This evidence concerns the gene NFKB1 and colorectal neoplasm.